ロード中...
Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
The fact that over 30% of current pharmaceuticals target heptahelical G protein–coupled receptors (GPCRs) attests to their tractability as drug targets. Although GPCR drug development has traditionally focused on conventional agonists and antagonists, the growing appreciation that GPCRs mediate phys...
保存先:
| 出版年: | Mol Pharmacol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4551052/ https://ncbi.nlm.nih.gov/pubmed/26134495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.099630 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|